Remission and Low Disease Activity in Granulomatosis With Polyangiitis and Microscopic Polyangiitis: Prevalence and Impact on Damage Accrual-Reference-Cited by-同舟云学术

Remission and Low Disease Activity in Granulomatosis With Polyangiitis and Microscopic Polyangiitis: Prevalence and Impact on Damage Accrual

Published:2022-12-21 Issue:5 Volume:75 Page:1158-1165
ISSN:2151-464X
Container-title:Arthritis Care & Research
language:en
Short-container-title:Arthritis Care & Research

Author:

Delvino Paolo¹^ORCID,Sardanelli Federica²,Monti Sara¹^ORCID,Cohen Pascal³,Puéchal Xavier³^ORCID,Mouthon Luc³,Montecucco Carlomaurizio¹,Guillevin Loïc³,Terrier Benjamin³^ORCID

Affiliation:

1. Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo Foundation, University of Pavia Pavia Italy

2. Ospedale Civile Sant'Andrea La Spezia Italy

3. Hôpital Cochin Paris France

Publisher

Wiley

Subject

Rheumatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr.24958

Reference22 articles.

1. Cyclophosphamide Therapy in Wegener's Granulomatosis

2. Wegener's Granulomatosis: Prospective Clinical and Therapeutic Experience With 85 Patients for 21 Years

3. Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force

4. Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: Analysis of four prospective trials including 278 patients

5. Development and initial validation of the vasculitis damage index for the standardized clinical assessment of damage in the systemic vasculitides

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Granulomatosis with polyangiitis: clinical characteristics and updates in diagnosis;Frontiers in Medicine;2024-08-27

2. Current treatment approach to ANCA-associated vasculitis;Current Opinion in Rheumatology;2023-10-09

3. Unmet needs in ANCA-associated vasculitis: Physicians’ and patients’ perspectives;Frontiers in Immunology;2023-02-23